A randomized single-blind trial of the effects of vitamins C and E in familial hypercholesterolemia;Ensayo aleatorizado ciego-sencillo sobre los efectos de las vitaminas C y E en la hipercolesterolemia familiar

Anales de Pediatria

Volumn 65, Issue 2, 2006, Pages 101-107

  Aldamiz Echevarria L ^a,c   Dalmau, J ^b   Prieto, J A ^a   Andrade, F ^a   Sanjurjo, P ^a   Elorz, J ^a   Rodriguez Soriano J ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL INFANTIL LA FE   (Spain)

^c HOSPITAL DE CRUCES   (Spain)

Author keywords

Children; Familial hypercholesterolemia; Linoleic acid; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; FATTY ACID; LINOLEIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FATTY ACID BLOOD LEVEL; FEMALE; HETEROZYGOSITY; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; MALE; NUTRITIONAL ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 33748779601     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13091477     Document Type: Article

References (29)

1. Hennermann JB, Herwig J, Márz W, Asskali F, Böhles HJ. Lipid and lipoprotein profiles in children with familial hypercholesterolemia: Effects of therapy. Eur J Pediatr. 1998;157:912-8.
2. Verma S, Szmitko PE, Anderson TJ. Endothelial function: Ready for prime time? Can J Cardiol 2004;20:1335-9.
3. Slyper AH. Clinical review 168: What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. J Clin Endocrinol Metab 2004;89:3089-95.
4. Böger PM. Bode-Böger S, Szuba A, Tsao P, Chan J, Tangphao O, et al. Asymetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation. 1998;98:1842-7.
5. McCrindle BW, Ose L, Marais AD. Efficacy and safety of atorvastatin in children and adolescents with familial hipercolesterolemia or severe hyperlipidemia: A multicentre randomized, placebo controlled trial. J Pediatr. 2003;143:74-80.
6. Shishehbor MH. Aviles RJ, Brennan ML, Fu X, Goormastic M, Pearce GL, et al. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA. 2003;289:1675-80.
7. Mietus-Snyder M, Malloy M. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: Improvement with antioxidant vitamin therapy. J Pediatr. 1998;133:35-40.
8. Verhaar MC, Wever RM, Kastelein JJ, Van Loon D, Milstien S, Koomans HA, et al. Effects of oral folk acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial. Circulation. 1999;100:335-8.
9. Lepage G, Roy CC. Direct transesterification of all classes of lipids in one step reaction. J Lip Res. 1986;27:114-21.
10. Obarzanek E, Kimm SY, Barton BA, Van Horn LL, Kwiterovich PO Jr, Simons-Morton DG, et al. Long term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: Seven year results of the Dietary Intervention Study in Children (DISC). Pediatrics. 2001;107:256-64.
11. Engler MM, Engler MB, Malloy MJ, Chiu EY, Schloetter MC, Paul SM, et al. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation. 2003;108:1059-63.
12. Nawawi H, Osman NS, Annuar R, Khalid BA, Yusoff K. Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolemia treated with atorvastatin. Atherosclerosis. 2003;169:283-91.
13. Bruunsgaard H, Poulsen HE, Pedersen BK, Nyyssonen K, Kaikkonen J, Salonen JT. Long-term combined supplementation with alpha-tocopherol and vitamin C have no detectable anti-inflammatory effects in healthy men. J Nutr. 2003;133:1170-3.
14. Salo P, Viikari J, Hamalainen M, Lapinleimu H, Routi T, Niinikoski, et al. Fatty acid composition of serum cholesterol esters as a reflector of low-saturated-fat, low-cholesterol diet in young children: The STRIP project. The Special Turku coronary Risk factor Intervention Project. Acta Paediatr. 2000;89:399-405.
15. Fielding BA, Frayn KN. Lipid metabolism. Curr Opin Lipidol. 2004;15:483-5.
16. Djoussé L, Pankow JS, Eckfeldt HJ, Folsom AR, Hopkins PN, Province MA, et al. Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr. 2001;74:612-9.
17. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH for the ARIC Study Investigators. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2003;78:86-92.
18. Laaksonen DE, Nyyssonen K, Niskanen L, Rissanen TH, Salonen JT. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med. 2005;165:193-9.
19. Ma J, Folsom AR, Shahar E, Eckfeldt JH, the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. Am J Clin Nutr. 1995;62:564-71.
20. Knekt P, Ritz J, Pereira MA, O'Reilly EJ, Augustsson K, Fraser GE, et al. Antioxidant vitamins and coronary heart disease risk: A pooled analysis of 9 cohorts. Am J Clin Nutr. 2004;80:1508-20.
21. Ling L, Zhao SP, Gao M, Zhou QC, Xia B. Vitamin C preserves endothelial function in patients with coronary heart disease after a high fat meal. Clin Cardiol. 2002;25:219-24.
22. Negre-Salvayre A, Mabile L, Delchambre J, Salvayre R. Alpha-tocopherol, ascorbic acid, and rutin inhibit synergistically the copper-promoted LDL oxidation and the cytotoxicity of oxidized LDL to cultured endothelial cells. Biol Trace Elem Res. 1995;47:81-91.
23. Landmesser U, Hornig B, Drexler H. Endothelial function. A critical determinant in atherosclerosis? Circulation. 2004;109 Suppl 11:27-33.
24. Gale CR, Ashurst HE, Powers HJ, Martín CN. Antioxidant vitamin status and carotid atherosclerosis in the elderly. Am J Clin Nutr. 2001;74:402-8.
25. Halcox JPJ, Deanfield JE. Endothelial cell function testing: How does the method help us in evaluating vascular status? Acta Paediatr. 2004;Suppl 446:48-54.
26. Sijbrands EJ, Westendorp RG, Defesche JC, De Meier PH, Smelt AH, Kastelein JJ. Mortality over two centuries in large pedigree with familial hypercholesterolemia: Family tree mortality study. BMJ. 2001;322:1019-23.
27. Hopkins PN, Stephenson S, Wu LL, Riley WA, Xin Y, Hunt SC. Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia. Am J Cardiol. 2001;87:547-53.
28. Rodenburg J, Vissers MN, Wiegman A, Trip MD, Bakker HD, Kastelein JJP. Familial hypercholesterolemia in children. Curr Opin Lipidol. 2004;15:405-11.
29. Wiegman A, De Groot E, Hutten BA, Rodenburg J, Gort J, Bakker HD, et al. Arterial intima-media thickness in children heterozygous for familial hypercholesterolemia. Lancet. 2004;363:369-70.